Gabapentin

Uses & side effects

Drug interactions

In equine medicine, Gabapentin is commonly used as an add-on therapy within multimodal pain management strategies for chronic lameness, laminitis, and neuropathic pain. While it is generally well-tolerated, its primary drug interactions relate to additive central nervous system (CNS) depression and gastrointestinal absorption or elimination dynamics rather than liver enzyme degradation (as it is not heavily metabolized by cytochrome P450 enzymes in mammals).The clinically relevant drug interactions for Gabapentin in horses are structured below:1. Central Nervous System (CNS) & Sedative InteractionsGabapentin can cross the blood-brain barrier and cause mild, transient drowsiness or tranquilizing effects, especially at higher or intravenous doses. Combining it with other CNS depressants results in an additive sedative effect:Alpha-2 Agonists (e.g., Xylazine, Detomidine, Romifidine): Concurrent use profoundly deepens sedation and muscle relaxation. Dosage reductions of the sedative are often required during standing chemical restraint.Opioids (e.g., Butorphanol, Morphine): Potentiates both the analgesic efficacy and the sedative side effects. Close monitoring for signs of profound ataxia or decreased gastrointestinal motility (colic risks) is recommended.Antihistamines: Medications like Pyrilamine or Hydroxyzine used for equine allergies will amplify drowsiness when coupled with Gabapentin.2. Gastrointestinal Absorption InterferencesBecause oral Gabapentin already exhibits a remarkably low bioavailability in horses (only ~16.2% due to poor absorption pathways), gastrointestinal environment alterations matter heavily:Oral Antacids: Compounds containing aluminum or magnesium hydroxide hinder the absorption of Gabapentin by up to 20%. Rule: Separate the administration of oral antacids and Gabapentin by a minimum of 2 hours.Gastric Ulcer Medications: While standard proton pump inhibitors like Omeprazole do not significantly alter Gabapentin, separating them from feeding/medication cycles helps preserve what little oral uptake the horse has.3. Renal Elimination RisksGabapentin is eliminated almost entirely unchanged by the kidneys. Co-administering it with drugs that alter renal perfusion or clearance can lead to drug accumulation and toxicities:Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (e.g., Phenylbutazone, Flunixin Meglumine, Firocoxib): Chronic, high-dose NSAID therapy can induce renal papillary necrosis or reduce renal blood flow. If the kidneys are compromised by NSAIDs, Gabapentin clearance slows down, raising the risk of prolonged sedation or ataxia.Positive (Synergistic) InteractionsIt is important to note that many interactions are intentional and therapeutic:Firocoxib (Equioxx): Studies demonstrate that while Gabapentin is often ineffective as a standalone monotherapy for chronic equine musculoskeletal pain, it acts synergistically with Firocoxib, significantly dropping pain scores when used as a multimodal adjuvant

Contraindications

xylazine, detomidine, romifidine, Butorphanol, Torbugesic, Pentazocine, Naltrexone, Dextropropoxyphene